Dicerna Pharmaceuticals CEO Douglas Fambrough's 2019 pay jumps 102% to $5M
Dicerna Pharmaceuticals reports 2019 executive compensation
By ExecPay News
Published: April 22, 2020
Dicerna Pharmaceuticals reported fiscal year 2019 executive compensation information on April 22, 2020.
In 2019, five executives at Dicerna Pharmaceuticals received on average a compensation package of $3M, a 98% increase compared to previous year.
Average pay of disclosed executives at Dicerna Pharmaceuticals
Douglas M. Fambrough, III, Chief Executive Officer, received $5M in total, which increased by 102% compared to 2018. 81% of Fambrough's compensation, or $4.1M, was in option awards. Fambrough also received $394K in non-equity incentive plan, $525K in salary, as well as $19K in other compensation.
Robert D. Ciappenelli, Chief Commercial Officer, received a compensation package of $3.6M. 90% of the compensation package, or $3.2M, was in option awards.
Ralf Rosskamp, Chief Medical Officer, earned $2.2M in 2019, a 111% increase compared to previous year.
Bob D. Brown, Chief Scientific Officer, received $2.1M in 2019, which increases by 66% compared to 2018.
John B. Green, Chief Financial Officer, earned $2.1M in 2019, a 67% increase compared to previous year.
Related executives
Douglas Fambrough
Dicerna Pharmaceuticals
Chief Executive Officer
John Green
Dicerna Pharmaceuticals
Chief Financial Officer
Bob Brown
Dicerna Pharmaceuticals
Chief Scientific Officer
Robert Ciappenelli
Dicerna Pharmaceuticals
Chief Commercial Officer
Ralf Rosskamp
Dicerna Pharmaceuticals
Chief Medical Officer
You may also like
Source: SEC filing on April 22, 2020.